PUBLISHER: 360iResearch | PRODUCT CODE: 1606662
PUBLISHER: 360iResearch | PRODUCT CODE: 1606662
DNA & Gene Chip Market by Product (Consumables, Instruments), Array Type (cDNA-Based Microarray, Oligonucleotide-Based Microarray), Application, End-User - Global Forecast 2025-2030
The DNA & Gene Chip Market was valued at USD 8.77 billion in 2023, expected to reach USD 9.71 billion in 2024, and is projected to grow at a CAGR of 11.34%, to USD 18.61 billion by 2030.
The DNA and Gene Chip market represents a specialized segment within the biotechnology and genomics field, focusing on technology facilitating the rapid analysis of gene expression and genetic variations. These chips, also called microarrays, are indispensable tools for advancing personalized medicine, diagnostics, and therapeutic development. Their necessity lies in enabling large-scale genomic research, accelerating drug discovery, and enhancing disease understanding. Applications span across oncology, pharmacogenomics, genetic analysis, and agricultural biotechnology, serving a wide range of end-users, including research labs, hospitals, and biopharmaceutical companies. The market is predominantly driven by the increasing demand for personalized medicine, technological advancements leading to cost-effective and high-throughput capabilities, and the expanding biotech industry. Furthermore, the rise in genetic disorders and cancer cases necessitates efficient diagnostic tools, providing potential growth opportunities.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 8.77 billion |
| Estimated Year [2024] | USD 9.71 billion |
| Forecast Year [2030] | USD 18.61 billion |
| CAGR (%) | 11.34% |
However, certain growth barriers include the high costs associated with technology and data management challenges due to the vast amount of information generated. Intellectual property issues also present obstacles. Opportunities for tapping into emerging markets, enhancing data analysis techniques, and integrating artificial intelligence present significant avenues for growth. Companies should focus on developing affordable and user-friendly microarray solutions to cater to small and medium-sized enterprises. Moreover, expanding applications in agriculture for crop improvement and animal genetics could open new revenue streams.
For innovation, investing in platform development that simplifies data interpretation and enhances accuracy will be key. Moreover, research could focus on combining microarray technology with CRISPR and next-generation sequencing for improved diagnostics and treatment strategies. Understanding the competitive landscape, marked by rapid technological shifts and stringent regulatory policies, can aid businesses in strategically positioning themselves in the market. With a robust growth outlook, the DNA and Gene Chip market holds substantial potential, but companies need to effectively address challenges and leverage technological advancements to capitalize on emerging opportunities.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving DNA & Gene Chip Market
The DNA & Gene Chip Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Growing need of DNA & gene chip for genetic analysis and diagnostics
- Surging adoption of personalized medicines for cancer treatments
- Increase in the demand for early cancer detection and cancer diagnosis
- Market Restraints
- Lack of skilled and experienced subject experts
- Market Opportunities
- Emerging miniaturization of DNA & gene chip
- Strategic government fundings and initiatives for DNA & gene chip
- Market Challenges
- Concern associated with gene expression regulation and availability of alternative technologies
Porter's Five Forces: A Strategic Tool for Navigating the DNA & Gene Chip Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the DNA & Gene Chip Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the DNA & Gene Chip Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the DNA & Gene Chip Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the DNA & Gene Chip Market
A detailed market share analysis in the DNA & Gene Chip Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the DNA & Gene Chip Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the DNA & Gene Chip Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the DNA & Gene Chip Market
A strategic analysis of the DNA & Gene Chip Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the DNA & Gene Chip Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Agilent Technologies, Inc., Arrayit Corporation, Biomerieux SA, Bioneer Corporation, CapitalBio Technology Co., Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Greiner Bio-One International GmbH, Illumina, Inc., Integrated Dna Technologies, LifeGen Technologies, LLC, Macrogen Inc., Merck KGaA, Microarrays Inc., Ocimum Biosolutions Ltd., Perkin Elmer, Inc., Promega Corporation, Savyon Diagnostics, Scienion AG by a Bico Company, Shanghai Biochip Co Ltd., Sophia Genetics SA, Surmodics Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Veritas Genetics, Inc..
Market Segmentation & Coverage
This research report categorizes the DNA & Gene Chip Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Product, market is studied across Consumables and Instruments.
- Based on Array Type, market is studied across cDNA-Based Microarray and Oligonucleotide-Based Microarray.
- Based on Application, market is studied across Diagnostics, Drug Discovery & Development, Genomics, and Personalized Medicine.
- Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Clinical Laboratories, and Pharmaceutical & Biotechnology Companies.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing need of DNA & gene chip for genetic analysis and diagnostics
- 5.1.1.2. Surging adoption of personalized medicines for cancer treatments
- 5.1.1.3. Increase in the demand for early cancer detection and cancer diagnosis
- 5.1.2. Restraints
- 5.1.2.1. Lack of skilled and experienced subject experts
- 5.1.3. Opportunities
- 5.1.3.1. Emerging miniaturization of DNA & gene chip
- 5.1.3.2. Strategic government fundings and initiatives for DNA & gene chip
- 5.1.4. Challenges
- 5.1.4.1. Concern associated with gene expression regulation and availability of alternative technologies
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. DNA & Gene Chip Market, by Product
- 6.1. Introduction
- 6.2. Consumables
- 6.3. Instruments
7. DNA & Gene Chip Market, by Array Type
- 7.1. Introduction
- 7.2. cDNA-Based Microarray
- 7.3. Oligonucleotide-Based Microarray
8. DNA & Gene Chip Market, by Application
- 8.1. Introduction
- 8.2. Diagnostics
- 8.3. Drug Discovery & Development
- 8.4. Genomics
- 8.5. Personalized Medicine
9. DNA & Gene Chip Market, by End-User
- 9.1. Introduction
- 9.2. Academic & Research Institutes
- 9.3. Hospitals & Clinical Laboratories
- 9.4. Pharmaceutical & Biotechnology Companies
10. Americas DNA & Gene Chip Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
11. Asia-Pacific DNA & Gene Chip Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
12. Europe, Middle East & Africa DNA & Gene Chip Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
13. Competitive Landscape
- 13.1. Market Share Analysis, 2023
- 13.2. FPNV Positioning Matrix, 2023
- 13.3. Competitive Scenario Analysis
- 13.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. 23andMe, Inc.
- 2. Agilent Technologies, Inc.
- 3. Arrayit Corporation
- 4. Biomerieux SA
- 5. Bioneer Corporation
- 6. CapitalBio Technology Co., Ltd.
- 7. Eurofins Scientific SE
- 8. F. Hoffmann-La Roche AG
- 9. Greiner Bio-One International GmbH
- 10. Illumina, Inc.
- 11. Integrated Dna Technologies
- 12. LifeGen Technologies, LLC
- 13. Macrogen Inc.
- 14. Merck KGaA
- 15. Microarrays Inc.
- 16. Ocimum Biosolutions Ltd.
- 17. Perkin Elmer, Inc.
- 18. Promega Corporation
- 19. Savyon Diagnostics
- 20. Scienion AG by a Bico Company
- 21. Shanghai Biochip Co Ltd.
- 22. Sophia Genetics SA
- 23. Surmodics Inc.
- 24. Sysmex Corporation
- 25. Thermo Fisher Scientific Inc.
- 26. Twist Bioscience Corporation
- 27. Veritas Genetics, Inc.
LIST OF FIGURES
- FIGURE 1. DNA & GENE CHIP MARKET RESEARCH PROCESS
- FIGURE 2. DNA & GENE CHIP MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 13. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 15. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 17. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 22. DNA & GENE CHIP MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 23. DNA & GENE CHIP MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. DNA & GENE CHIP MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. DNA & GENE CHIP MARKET DYNAMICS
- TABLE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CDNA-BASED MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL DNA & GENE CHIP MARKET SIZE, BY OLIGONUCLEOTIDE-BASED MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL DNA & GENE CHIP MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 22. AMERICAS DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 23. AMERICAS DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 24. AMERICAS DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 25. AMERICAS DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 26. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 27. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 28. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 29. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 30. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 31. BRAZIL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 32. BRAZIL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 33. BRAZIL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 34. BRAZIL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 35. CANADA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 36. CANADA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 37. CANADA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 38. CANADA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 39. MEXICO DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 40. MEXICO DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 41. MEXICO DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 42. MEXICO DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 43. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 44. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 45. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 46. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 47. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 48. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 49. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 50. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 51. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 52. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 53. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 54. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 55. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 56. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 57. CHINA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 58. CHINA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 59. CHINA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 60. CHINA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 61. INDIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 62. INDIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 63. INDIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 64. INDIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 65. INDONESIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 66. INDONESIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 67. INDONESIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 68. INDONESIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 69. JAPAN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 70. JAPAN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 71. JAPAN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 72. JAPAN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 73. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 74. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 75. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 76. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 77. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 78. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 79. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 80. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 81. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 82. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 83. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 84. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 85. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 86. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 87. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 88. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 89. TAIWAN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 90. TAIWAN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 91. TAIWAN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 92. TAIWAN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 93. THAILAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 94. THAILAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 95. THAILAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 96. THAILAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 97. VIETNAM DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 98. VIETNAM DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 99. VIETNAM DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 100. VIETNAM DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 101. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 102. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 103. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 104. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 105. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 106. DENMARK DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 107. DENMARK DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 108. DENMARK DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 109. DENMARK DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 110. EGYPT DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 111. EGYPT DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 112. EGYPT DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 113. EGYPT DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 114. FINLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 115. FINLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 116. FINLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 117. FINLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 118. FRANCE DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 119. FRANCE DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 120. FRANCE DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 121. FRANCE DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 122. GERMANY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 123. GERMANY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 124. GERMANY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 125. GERMANY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 126. ISRAEL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 127. ISRAEL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 128. ISRAEL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 129. ISRAEL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 130. ITALY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 131. ITALY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 132. ITALY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 133. ITALY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 134. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 135. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 136. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 137. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 138. NIGERIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 139. NIGERIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 140. NIGERIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 141. NIGERIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 142. NORWAY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 143. NORWAY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 144. NORWAY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 145. NORWAY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 146. POLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 147. POLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 148. POLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 149. POLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 150. QATAR DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 151. QATAR DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 152. QATAR DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 153. QATAR DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 154. RUSSIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 155. RUSSIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 156. RUSSIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 157. RUSSIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 158. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 159. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 160. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 161. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 162. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 163. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 164. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 165. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 166. SPAIN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 167. SPAIN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 168. SPAIN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 169. SPAIN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 170. SWEDEN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 171. SWEDEN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 172. SWEDEN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 173. SWEDEN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 174. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 175. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 176. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 177. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 178. TURKEY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 179. TURKEY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 180. TURKEY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 181. TURKEY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 182. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 183. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 184. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 185. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 186. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 187. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
- TABLE 188. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 189. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 190. DNA & GENE CHIP MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 191. DNA & GENE CHIP MARKET, FPNV POSITIONING MATRIX, 2023
